ADVFN - News

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Symbol:

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
03/29/2025	10:15PM	PR Newswire (Canada)	Jean Morin de la Fromagerie du Presbytère nommé Personnalité du monde alimentaire 2025
03/29/2025	10:00PM	PR Newswire (Canada)	CCA Financial acquiert un portefeuille de financement de Macquarie Equipment Finance Ltd. et élargit sa présence nord-américaine avec un nouveau bureau à Toronto
03/29/2025	7:45PM	GlobeNewswire Inc.	Ambia Solar Headquarters Move to Lindon, Utah
03/29/2025	6:30PM	PR Newswire (US)	Hisense Broadband Multimedia Technologies Co., Ltd. (HBMT) forms Ligent Inc. by Consolidating North American and Thailand Operations
03/29/2025	4:29PM	PR Newswire (Canada)	Gstar accélère l'implantation de l'usine indonésienne de plaquettes de silicium avec l'expédition de l'équipement
03/29/2025	3:30PM	GlobeNewswire Inc.	Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
03/29/2025	3:30PM	GlobeNewswire Inc.	HII Celebrates 2024 Graduates of The Newport News Shipbuilding Apprentice School	NYSE:HII	Huntington Ingalls Industries Inc
03/29/2025	3:22PM	PR Newswire (US)	Think you can do better than your team's GM? Ultra GM gives you that chance.
03/29/2025	3:11PM	PR Newswire (US)	Family of Yuyu Dong (outside of China) Available After Appeals Hearing Monday
03/29/2025	3:09PM	PR Newswire (Canada)	Hisense présente son nouveau téléviseur ULED MiniLED de la série U7, qui porte l'expérience des jeux et du sport à de nouveaux sommets
03/29/2025	2:30PM	GlobeNewswire Inc.	Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)	NASDAQ:MLYS	Mineralys Therapeutics Inc
03/29/2025	2:30PM	PR Newswire (US)	Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
03/29/2025	2:27PM	PR Newswire (US)	With Renovation Approaching, Final Dubai Fountain Show Date Unveiled
03/29/2025	2:22PM	PR Newswire (US)	With Renovation Approaching, Final Dubai Fountain Show Date Unveiled
03/29/2025	2:21PM	Business Wire	Vivendi Signs an Agreement With Poste Italiane for the Sale of TIM Shares	NYSE:VIV	Telefonica Brasil SA
03/29/2025	2:21PM	Business Wire	Vivendi signe avec Poste Italiane un accord de cession de titres TIM	NYSE:VIV	Telefonica Brasil SA
03/29/2025	1:00PM	Business Wire	Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025	NASDAQ:ALNY	Alnylam Pharmaceuticals Inc
03/29/2025	1:00PM	PR Newswire (Canada)	/R E P E A T -- MEDIA ADVISORY - Game on, Grandma! Calgary Pickleball Club serves up youth program/
03/29/2025	1:00PM	PR Newswire (US)	Explore the 2025 Ford Bronco Trim Level Research: Find Your Perfect Off-Road Adventure Companion at Akins Ford near Atlanta, GA
03/29/2025	12:58PM	PR Newswire (US)	UtahRealEstate.com Partners with Inside Real Estate to Give Members an Advertising Platform to Promote Listings on Facebook and Instagram
03/29/2025	12:55PM	PR Newswire (US)	How Medical Malpractice Cases Work in Florida: What Victims Need to Know
03/29/2025	12:55PM	PR Newswire (US)	Human Appeal Mobilizes 13 thousand Food & Shelter Kits in Myanmar Earthquake response
03/29/2025	12:32PM	GlobeNewswire Inc.	SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding
03/29/2025	12:08PM	Business Wire	欧州医薬品庁（EMA）、ヘンリウスおよびオルガノンによるパージェタ（Perjeta ®）（ペルツズマブ）のバイオシミラー候補HLX11の申請を受理	NYSE:OGN	Organon and Co
03/29/2025	12:08PM	Business Wire	L’Agence européenne des médicaments (EMA) valide le dépôt par Henlius et Organon du candidat biosimilaire de Perjeta® (pertuzumab) HLX11	NYSE:OGN	Organon and Co
03/29/2025	12:08PM	Business Wire	Europäische Arzneimittelagentur (EMA) validiert Antrag von Henlius und Organon für Perjeta® (Pertuzumab) Biosimilar-Kandidat HLX11	NYSE:OGN	Organon and Co
03/29/2025	12:05PM	FinanceWire	PU Prime Becomes the Official Regional Sponsor of the Argentina National Football Team
03/29/2025	11:58AM	GlobeNewswire Inc.	Saephan Companies Join the Unicorn Market: Johny Saephan Becomes First Mien-Thai American AI Billionaire with $1B Pre-Valuation Tied to Aisles Investment
03/29/2025	11:25AM	PR Newswire (US)	Franchise FastLane Partners with MaxStrength Fitness to Propel Growth
03/29/2025	10:30AM	GlobeNewswire Inc.	BexBack Launches 100x Leverage, Double Deposit Bonus, and $50 Welcome Bonus — No KYC Required

1 2 3 4 5 6 7 8 9 10 Next >>

Lehman Brothers Financial (CE)

Kraig Biocraft Laborator... (QB)

Rennova Health (CE)

Elite Pharmaceuticals (QB)

Liquidmetal Technologies (QB)

Bioelectronics (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Fannie Mae (QB)

Lightwave Logic

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions